Asia Pacific Positive Airway Pressure (PAP) Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Asia Pacific positive airway pressure (PAP) devices market size is expected to reach US$ 2,394.30 million by 2031 from US$ 1,341.04 million in 2023. The market is estimated to record a CAGR of 7.5% from 2023 to 2031.

Executive Summary and Asia Pacific Positive Airway Pressure (PAP) Devices Market Analysis:

The Asia Pacific PAP devices market in is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is attributed to the increasing aging population, growing patient pool suffering from obstructive sleep apnea, technological advancements in PAP devices, increasing prevalence of chronic obstructive pulmonary disease (COPD), and the shift of care from hospital to home care.

Asia Pacific Positive Airway Pressure (PAP) Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Asia Pacific Positive Airway Pressure (PAP) Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Asia Pacific positive airway pressure (PAP) devices market analysis are product type, application, and end user.

• Based on product type, the Asia Pacific positive airway pressure (PAP) devices market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. The continuous positive airway pressure (CPAP) devices held the largest share of the market in 2023.
• Based on application, the Asia Pacific positive airway pressure (PAP) devices market is segmented into chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea held the largest share of the market in 2023.
• Based on end user, the Asia Pacific positive airway pressure (PAP) devices market is segmented into hospitals, ambulatory surgical centers, home care, and rehabilitation centers. The hospitals held the largest share of the market in 2023.

Asia Pacific Positive Airway Pressure (PAP) Devices Market Outlook

Patients largely prefer availing treatment in the convenience and comfort of their homes over clinical settings. PAP devices work well in home-care settings to treat sleep apnea and other respiratory disorders, which relieves the burden on healthcare facilities and promotes consistent use of PAP devices. Sleep apnea and many other respiratory disorders require long-term therapy. By providing long-term, at-home solutions, PAP devices promote cost-effectiveness.

The shift toward home healthcare directly drives the sales of PAP devices designed for home use. Thus, manufacturers focus on producing user-friendly, portable, and efficient devices for this expanding market. For example, ResMed manufactured the AirMini Portable CPAP used in home care. It influences the market by pushing innovation, creating the need for home-use devices, and improving access to respiratory care in developed and developing nations. As healthcare systems are increasingly prioritizing home-based treatment options, this inclination is predicted to continue.

Asia Pacific Positive Airway Pressure (PAP) Devices Market Country Insights

Based on country, the Asia Pacific positive airway pressure (PAP) devices market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.

China is expected to be the largest market for PAP devices in Asia Pacific. The market growth in the country is attributed to increasing number of new product approvals, growing geriatric population's vulnerability to sleep apnea, and increasing prevalence of respiratory diseases. China is one of the fastest developing economies in Asia Pacific, with a GDP of US$ 18 trillion, accounting for 18% of the global economy, and healthcare expenditure accounts for 7.1% of the GDP. As per China Macro Economy Journal 2021, around 264 million people aged above 60 years account for 18.7% of the total population in China. The presence of a large geriatric population has increased the respiratory disease burden. As per the Frontier Media Public Health report published in June 2022, the recent Chinese national survey of COPD reported China accounted for ~25% of all COPD cases globally. As compared to the survey results 10 years ago, the prevalence of COPD has increased by 67% in people aged 40 years or above and has reached epidemic proportions. Moreover, asthma is estimated to be a significant public health challenge in the country. According to the National Library of Medicine, the prevalence of asthma was 4.2%, which represented 45.7 million people in the country in 2019, further increasing the demand for PAP devices.

Asia Pacific Positive Airway Pressure (PAP) Devices Market Report Highlights

Asia Pacific Positive Airway Pressure (PAP) Devices Market Company Profiles

Some of the key players operating in the market include ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Positive Airway Pressure (PAP) Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Asia Pacific Positive Airway Pressure (PAP) Devices Market Country and Regional Insights